Source: PLOS ONE. Unidade: FMRP
Subjects: ARTRITE REUMATOIDE, ADESÃO À MEDICAÇÃO, FÁRMACOS SINTÉTICOS, ESTUDOS TRANSVERSAIS, METOTREXATO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
GOMIDES, Ana Paula Monteiro et al. Causes of synthetic disease-modifying drug discontinuation in rheumatoid arthritis: Data from a large real-life cohort. PLOS ONE, v. 14, n. 3, p. e0213219, 2019Tradução . . Disponível em: https://doi.org/10.1371/journal.pone.0213219. Acesso em: 10 jun. 2024.APA
Gomides, A. P. M., Albuquerque, C. P. de, Santos, A. B. V., Amorim, R. B. C., Bertolo, M. B., Louzada Júnior, P., et al. (2019). Causes of synthetic disease-modifying drug discontinuation in rheumatoid arthritis: Data from a large real-life cohort. PLOS ONE, 14( 3), e0213219. doi:10.1371/journal.pone.0213219NLM
Gomides APM, Albuquerque CP de, Santos ABV, Amorim RBC, Bertolo MB, Louzada Júnior P, Santos IA, Giorgi RDN, Sacilotto N de C, Radominski SC. Causes of synthetic disease-modifying drug discontinuation in rheumatoid arthritis: Data from a large real-life cohort [Internet]. PLOS ONE. 2019 ; 14( 3): e0213219.[citado 2024 jun. 10 ] Available from: https://doi.org/10.1371/journal.pone.0213219Vancouver
Gomides APM, Albuquerque CP de, Santos ABV, Amorim RBC, Bertolo MB, Louzada Júnior P, Santos IA, Giorgi RDN, Sacilotto N de C, Radominski SC. Causes of synthetic disease-modifying drug discontinuation in rheumatoid arthritis: Data from a large real-life cohort [Internet]. PLOS ONE. 2019 ; 14( 3): e0213219.[citado 2024 jun. 10 ] Available from: https://doi.org/10.1371/journal.pone.0213219